Definium Therapeutics (NASDAQ:DFTX) Q3 2026 Earnings Call
Definium Therapeutics (NASDAQ:DFTX) reports Q3 2026 results on this call. Live coverage runs here, and the full replay with transcript and chapters lands on this page after the call.
- Company
- Definium Therapeutics, Inc. (NASDAQ:DFTX)
- Period
- Q3 2026 earnings call
- Date
- Mon, Nov 9, 2026, 4:30 PM ET
On 6ix: 6ix.com/event/definium-therapeutics-inc-dftx-q3-2026-earnings-call
Latest news releases
- NASDAQ:DFTX — Definium Therapeutics Presents Topline Phase 3 Data for DT120 ODT in Generalized Anxiety Disorder and Major Depressive Disorder at 2026 NEI Fall Congress · Wed, Nov 4, 2026
- NASDAQ:DFTX — Definium Therapeutics to Participate at Upcoming Investor Conferences · Tue, Nov 3, 2026